skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


  • NSF Public Access
  • Search Results
  • Detecting Depression and Predicting its Onset Using Longitudinal Symptoms Captured by Passive Sensing: A Machine Learning Approach With Robust Feature Selection
Title: Detecting Depression and Predicting its Onset Using Longitudinal Symptoms Captured by Passive Sensing: A Machine Learning Approach With Robust Feature Selection
We present a machine learning approach that uses data from smartphones and fitness trackers of 138 college students to identify students that experienced depressive symptoms at the end of the semester and students whose depressive symptoms worsened over the semester. Our novel approach is a feature extraction tech- nique that allows us to select meaningful features indicative of depressive symptoms from longitudinal data. It allows us to detect the presence of post-semester depressive symptoms with an accuracy of 85.7% and change in symptom severity with an accuracy of 85.4%. It also predicts these outcomes with an accuracy of >80%, 11–15 weeks before the end of the semester, allowing ample time for pre-emptive interventions. Our work has significant implications for the detection of health outcomes using longitudinal behavioral data and limited ground truth. By detecting change and predicting symptoms several weeks before their onset, our work also has implications for preventing depression.  more » « less
Award ID(s):
2009977
PAR ID:
10287368
Author(s) / Creator(s):
Date Published:
Journal Name:
ACM transactions on humanrobot interaction
Volume:
28
Issue:
1
ISSN:
2573-9522
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ; ; ; ; ; ; ; ; et al (, Neuropsychopharmacology)
    null (Ed.)
    Abstract Heterogeneity in the clinical presentation of major depressive disorder and response to antidepressants limits clinicians’ ability to accurately predict a specific patient’s eventual response to therapy. Validated depressive symptom profiles may be an important tool for identifying poor outcomes early in the course of treatment. To derive these symptom profiles, we first examined data from 947 depressed subjects treated with selective serotonin reuptake inhibitors (SSRIs) to delineate the heterogeneity of antidepressant response using probabilistic graphical models (PGMs). We then used unsupervised machine learning to identify specific depressive symptoms and thresholds of improvement that were predictive of antidepressant response by 4 weeks for a patient to achieve remission, response, or nonresponse by 8 weeks. Four depressive symptoms (depressed mood, guilt feelings and delusion, work and activities and psychic anxiety) and specific thresholds of change in each at 4 weeks predicted eventual outcome at 8 weeks to SSRI therapy with an average accuracy of 77% ( p  = 5.5E-08). The same four symptoms and prognostic thresholds derived from patients treated with SSRIs correctly predicted outcomes in 72% ( p  = 1.25E-05) of 1996 patients treated with other antidepressants in both inpatient and outpatient settings in independent publicly-available datasets. These predictive accuracies were higher than the accuracy of 53% for predicting SSRI response achieved using approaches that (i) incorporated only baseline clinical and sociodemographic factors, or (ii) used 4-week nonresponse status to predict likely outcomes at 8 weeks. The present findings suggest that PGMs providing interpretable predictions have the potential to enhance clinical treatment of depression and reduce the time burden associated with trials of ineffective antidepressants. Prospective trials examining this approach are forthcoming. 
    more » « less
  2. ; ; ; ; ; ; ; ; ; ; et al (, npj Digital Medicine)
    Abstract Over the last ten years, there has been considerable progress in using digital behavioral phenotypes, captured passively and continuously from smartphones and wearable devices, to infer depressive mood. However, most digital phenotype studies suffer from poor replicability, often fail to detect clinically relevant events, and use measures of depression that are not validated or suitable for collecting large and longitudinal data. Here, we report high-quality longitudinal validated assessments of depressive mood from computerized adaptive testing paired with continuous digital assessments of behavior from smartphone sensors for up to 40 weeks on 183 individuals experiencing mild to severe symptoms of depression. We apply a combination of cubic spline interpolation and idiographic models to generate individualized predictions of future mood from the digital behavioral phenotypes, achieving high prediction accuracy of depression severity up to three weeks in advance (R2≥ 80%) and a 65.7% reduction in the prediction error over a baseline model which predicts future mood based on past depression severity alone. Finally, our study verified the feasibility of obtaining high-quality longitudinal assessments of mood from a clinical population and predicting symptom severity weeks in advance using passively collected digital behavioral data. Our results indicate the possibility of expanding the repertoire of patient-specific behavioral measures to enable future psychiatric research. 
    more » « less
  3. (, Clinical psychological science)
    Few studies have used longitudinal approaches to consider the cumulative impact of COVID-19-related stressors (CRSs) on the psychological adjustment of mothers and children. In the current study, we tracked changes in maternal depressive symptoms and children’s behavioral problems from approximately 2 years before the pandemic (T1) to May through August 2020 (T2). Second, we explored maternal hair cortisol and dehydroepiandrosterone as predictors of change in maternal depressive symptoms. Mothers (N = 120) reported on maternal and child psychological adjustment at both time points. Hair hormone data were collected in the lab at T1. Results suggest increases in children’s internalizing symptoms from T1 to T2 and that higher levels of CRSs were associated with increased maternal depressive symptoms. Maternal and child adjustment were correlated. Maternal hair cortisol, but not dehydroepiandrosterone, was associated with significant increases in depressive symptoms. Findings underscore the importance of considering the family system and cumulative risk exposure on maternal and child mental health. 
    more » « less
  4. ; ; ; ; ; (, Clinical Psychological Science)
    Few studies have used longitudinal approaches to consider the cumulative impact of COVID-19-related stressors (CRSs) on the psychological adjustment of mothers and children. In the current study, we tracked changes in maternal depressive symptoms and children’s behavioral problems from approximately 2 years before the pandemic (T1) to May through August 2020 (T2). Second, we explored maternal hair cortisol and dehydroepiandrosterone as predictors of change in maternal depressive symptoms. Mothers ( N = 120) reported on maternal and child psychological adjustment at both time points. Hair hormone data were collected in the lab at T1. Results suggest increases in children’s internalizing symptoms from T1 to T2 and that higher levels of CRSs were associated with increased maternal depressive symptoms. Maternal and child adjustment were correlated. Maternal hair cortisol, but not dehydroepiandrosterone, was associated with significant increases in depressive symptoms. Findings underscore the importance of considering the family system and cumulative risk exposure on maternal and child mental health. 
    more » « less
  5. ; ; ; ; ; ; ; ; ; ; et al (, Journal of Child Psychology and Psychiatry)
    BackgroundThe treatment of depression in children and adolescents is a substantial public health challenge. This study examined artificial intelligence tools for the prediction of early outcomes in depressed children and adolescents treated with fluoxetine, duloxetine, or placebo. MethodsThe study samples included training datasets (N = 271) from patients with major depressive disorder (MDD) treated with fluoxetine and testing datasets from patients with MDD treated with duloxetine (N = 255) or placebo (N = 265). Treatment trajectories were generated using probabilistic graphical models (PGMs). Unsupervised machine learning identified specific depressive symptom profiles and related thresholds of improvement during acute treatment. ResultsVariation in six depressive symptoms (difficulty having fun, social withdrawal, excessive fatigue, irritability, low self‐esteem, and depressed feelings) assessed with the Children’s Depression Rating Scale‐Revised at 4–6 weeks predicted treatment outcomes with fluoxetine at 10–12 weeks with an average accuracy of 73% in the training dataset. The same six symptoms predicted 10–12 week outcomes at 4–6 weeks in (a) duloxetine testing datasets with an average accuracy of 76% and (b) placebo‐treated patients with accuracies of 67%. In placebo‐treated patients, the accuracies of predicting response and remission were similar to antidepressants. Accuracies for predicting nonresponse to placebo treatment were significantly lower than antidepressants. ConclusionsPGMs provided clinically meaningful predictions in samples of depressed children and adolescents treated with fluoxetine or duloxetine. Future work should augment PGMs with biological data for refined predictions to guide the selection of pharmacological and psychotherapeutic treatment in children and adolescents with depression. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Save / Share this Record
  • Send to Email